| Jun 5 |
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
|
| Jun 4 |
Axsome Therapeutics Joins the American Migraine Foundation to Highlight Unmet Treatment Needs During Migraine & Headache Awareness Month
|
| Jun 3 |
Axsome Therapeutics Supports Alzheimer’s & Brain Awareness Month
|
| May 30 |
Axsome Therapeutics to Participate in Upcoming Investor Conferences
|
| May 29 |
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
|
| May 28 |
Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting
|
